Jasmine Sun

So I think overall, I understood why you might want spaces of...

freedom or spaces of experimentation that shouldn't hit the mainstream.

I frankly don't want to hit the mainstream, should not be legitimized, should not be advertised or marketed, but that allow people to start poking around the edges.

With Silicon Valley in particular, one thing I think is, if this stuff really works,

then someone is going to invest a lot of money and then taking it through the rest of the process and figuring out the legal barriers and figuring out the clinical testing.

And if like one guy in his basement with some syringes is like the thing that, you know, makes someone realize maybe there's a there there and we're going to actually run the test now, then I am happy for that to happen.

I think that's right.

Yeah.

I think we need some people who are...

More risk-tolerant than the rest of us who are on the frontier.

I mean, this kind of goes back to your earlier question about why cover San Francisco.

Like, I like living in San Francisco.

Sometimes people are like, I can't believe you have to deal with these people and talk to these, like, crazy tech people all the time.

And I'm like, I love it because I am not as risk-tolerant as a lot of these people are.

I am not injecting the peptides.

I am not pouring all my money into crypto, etc., etc.

But I think that sometimes when you have people willing to take crazy risks, including failing like a lot of the time and screwing stuff up, the rest of us can learn from that.

And again, maybe we'll get something good out of it.

Maybe we won't, but maybe we will.

Most folks these days actually know peptide as the P in GLP-1s, which are glucagon-like peptide agonists.